Flexgrip Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
19

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10.9M
- Investors
-
9
Flexgrip General Information
Description
Developer of a catheter stabilization devices designed to secure catheters safely and efficiently. The company's devices help to shower and move around autonomously with a connected intravenous catheter, enabling patients to increase their comfort and reduce hospital time and material costs.
Contact Information
Website
www.flex-grip.comCorporate Office
- 3590 Diepenbeek
- Agoralaan Abis
- 3590 Diepenbeek
- Belgium
Corporate Office
- 3590 Diepenbeek
- Agoralaan Abis
- 3590 Diepenbeek
- Belgium
Flexgrip Timeline
Flexgrip Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC | 12-Jul-2024 | $10.9M | Completed | Generating Revenue | ||
6. Later Stage VC | 06-Oct-2022 | Completed | Generating Revenue | |||
5. Grant | 10-Jul-2019 | Completed | Generating Revenue | |||
4. Accelerator/Incubator | 14-May-2019 | Completed | Generating Revenue | |||
3. Later Stage VC (Series B) | 09-Oct-2018 | Completed | Generating Revenue | |||
2. Grant | 10-Mar-2017 | $10.6K | $590K | Completed | Generating Revenue | |
1. Early Stage VC | 12-May-2015 | $590K | $590K | Completed | Generating Revenue |
Flexgrip Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
D Shares | ||||||||
D Shares | ||||||||
C shares | ||||||||
Category C | ||||||||
Category C | ||||||||
Category C | 906 | $47.85 | $47.85 | 1x | $47.85 | 0.71% | ||
Pref | 23,300 | $24.8 | $24.8 | 1x | $24.8 | 18.15% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Flexgrip Patents
Flexgrip Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250082905-A1 | Anchoring system | Pending | 08-Sep-2023 | ||
EP-4171706-A1 | Catheter fixation device | Pending | 29-Jun-2020 | ||
US-20230310809-A1 | Catheter fixation device | Pending | 29-Jun-2020 | ||
CA-3163179-A1 | Catheter retaining device | Pending | 29-Nov-2019 | ||
US-20230001153-A1 | Catheter retaining device | Pending | 29-Nov-2019 | A61M25/02 |
Flexgrip Signals
Flexgrip Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Société Fédérale de Participations et d'Investissement | Corporation | Minority | ||
White Fund | PE/Buyout | Minority | ||
Dyfan Investment | Impact Investing | Minority | ||
VLAIO | Limited Partner | Minority | ||
EIT Health | Accelerator/Incubator |
Flexgrip FAQs
-
When was Flexgrip founded?
Flexgrip was founded in 2011.
-
Where is Flexgrip headquartered?
Flexgrip is headquartered in Diepenbeek, Belgium.
-
What is the size of Flexgrip?
Flexgrip has 19 total employees.
-
What industry is Flexgrip in?
Flexgrip’s primary industry is Therapeutic Devices.
-
Is Flexgrip a private or public company?
Flexgrip is a Private company.
-
What is the current valuation of Flexgrip?
The current valuation of Flexgrip is
. -
What is Flexgrip’s current revenue?
The current revenue for Flexgrip is
. -
How much funding has Flexgrip raised over time?
Flexgrip has raised $17.8M.
-
Who are Flexgrip’s investors?
Société Fédérale de Participations et d'Investissement, White Fund, Dyfan Investment, VLAIO, and EIT Health are 5 of 9 investors who have invested in Flexgrip.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »